Ocugen (OCGN) Gains from Sales and Divestitures (2015 - 2017)
Ocugen (OCGN) reported Gains from Sales and Divestitures of $1889.0 for Q4 2017, down 42.77% on a YoY basis from $3301.0 in Q4 2016, and little changed quarter-over-quarter from $1889.0 in Q3 2017.
Ocugen (OCGN) Gains from Sales and Divestitures (2015 - 2017) Analysis & Trends
Ocugen has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $1889.0 in Q4 2017.
- For the quarter ending Q4 2017, Gains from Sales and Divestitures fell 42.77% year-over-year to $1889.0; the trailing twelve-month figure through Dec 2017 stood at $1889.0 (down 42.77% YoY), and the FY2017 full-year result was $1889.0, down 42.77% from the prior year.
- Gains from Sales and Divestitures for Q4 2017 stood at $1889.0, roughly flat from $1889.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $3303.0 in Q4 2015, with the low at $1889.0 in Q2 2015.
- Historically, Gains from Sales and Divestitures has averaged $2203.0 across 3 years, with a median of $1889.0 in 2015.
- Annual changes were most pronounced in 2016 — Gains from Sales and Divestitures changed 0.0% — and 2017, when it slumped 42.77%.
- Ocugen's Gains from Sales and Divestitures stood at $3303.0 in 2015, then fell by 0.06% to $3301.0 in 2016, then slumped by 42.77% to $1889.0 in 2017.
- The last three Gains from Sales and Divestitures figures came in at $1889.0 (Q4 2017), $1889.0 (Q3 2017), and $1889.0 (Q2 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 1,889.00 |
| Dec 31, 2017 | 1,889.00 |
| Sep 30, 2017 | 1,889.00 |
| Sep 30, 2017 | 1,889.00 |
| Jun 30, 2017 | 1,889.00 |
| Jun 30, 2017 | 1,889.00 |
| Dec 31, 2016 | 3,301.00 |
| Dec 31, 2016 | 3,301.00 |
| Sep 30, 2016 | 1,889.00 |
| Sep 30, 2016 | 1,889.00 |
| Jun 30, 2016 | 1,889.00 |
| Jun 30, 2016 | 1,889.00 |
| Dec 31, 2015 | 3,303.00 |
| Dec 31, 2015 | 3,303.00 |
| Sep 30, 2015 | 1,889.00 |
| Sep 30, 2015 | 1,889.00 |
| Jun 30, 2015 | 1,889.00 |
| Jun 30, 2015 | 1,889.00 |